TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International, Inc. announced the grant of 834,433 Award Shares to its employees under the Post-IPO Share Award Scheme, representing approximately 0.03% of the total issued shares. The shares will vest over various periods ranging from 0.25 to 4 years, with no performance targets attached. This move aims to incentivize employees and align their interests with the company’s growth, potentially enhancing employee retention and satisfaction.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International, Inc. operates in the healthcare industry, primarily focusing on providing online healthcare services and products. The company is known for its digital health platform that offers a wide range of medical services, including telemedicine consultations, online pharmacy, and health management solutions.
Average Trading Volume: 12,220,643
Technical Sentiment Signal: Hold
Current Market Cap: HK$138.6B
For an in-depth examination of 6618 stock, go to TipRanks’ Overview page.